Traws Pharma, Inc. (TRAW) Earnings History
Annual and quarterly earnings data from 2011 to 2024
Loading earnings history...
TRAW EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
TRAW Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 94.7% | -21835.4% | -24192.0% |
| 2023 | 100.0% | -8981.4% | -8384.1% |
| 2022 | 100.0% | -8684.5% | -8391.2% |
| 2021 | 100.0% | -7299.1% | -7151.8% |
| 2020 | 100.0% | -10819.5% | -10890.5% |
Download Data
Export TRAW earnings history in CSV or JSON format
Free sign-in required to download data
Traws Pharma, Inc. (TRAW) Earnings Overview
As of May 8, 2026, Traws Pharma, Inc. (TRAW) reported trailing twelve-month net income of -$23M, reflecting -56.0% year-over-year growth. The company earned $-3.95 per diluted share over the past four quarters, with a net profit margin of -24192.0%.
Looking at the long-term picture, TRAW's historical earnings data spans multiple years. The company achieved its highest annual net income of -$16M in fiscal 2021.
Traws Pharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including VRTX ($4.34B net income, 32.7% margin), IMVT (-$464M net income), GILD ($9.22B net income, 28.9% margin), TRAW has room to improve margins relative to the peer group. Compare TRAW vs VRTX →
TRAW Earnings vs Peers
Earnings metrics vs comparable public companies
TRAW Historical Earnings Data (2011–2024)
14 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$55M | -188.5% | -$49M | $-35.21 | -24192.0% | -21835.4% |
| 2023 | -$19M | +0.1% | -$20M | $-22.57 | -8384.1% | -8981.4% |
| 2022 | -$19M | -17.3% | -$20M | $-22.68 | -8391.2% | -8684.5% |
| 2021 | -$16M | +35.8% | -$16M | $-24.01 | -7151.8% | -7299.1% |
| 2020 | -$25M | -17.0% | -$25M | $-54.21 | -10890.5% | -10819.5% |
| 2019 | -$22M | -4.5% | -$22M | $-560.58 | -985.0% | -994.0% |
| 2018 | -$21M | +14.6% | -$23M | $-1870.69 | -1675.3% | -1895.9% |
| 2017 | -$24M | -22.5% | -$26M | $-15056.00 | -3061.2% | -3270.3% |
| 2016 | -$20M | +18.0% | -$24M | $-24975.00 | -354.6% | -427.4% |
| 2015 | -$24M | +62.3% | -$24M | $-59062.00 | -209.3% | -209.3% |
See TRAW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TRAW Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TRAW vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTRAW — Frequently Asked Questions
Quick answers to the most common questions about buying TRAW stock.
Is TRAW growing earnings?
TRAW EPS fell to $-3.95, with earnings declining -56.0%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-23M.
What are TRAW's profit margins?
Traws Pharma, Inc. net margin is -24192.0%, with operating margin at -21835.4%. Below-average margins reflect competitive or cost pressures.
How consistent are TRAW's earnings?
TRAW earnings data spans 2011-2024. The declining earnings trend is -56.0% YoY. Historical data enables comparison across business cycles.